Cargando…
Use of albumin in spontaneous bacterial peritonitis is cost-effective
Autores principales: | Farrugia, A, Bansal, M, Caraceni, P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4472242/ http://dx.doi.org/10.1186/cc14433 |
Ejemplares similares
-
Estimation of the latent therapeutic demand for albumin in the USA: a focus on three indications
por: Farrugia, A, et al.
Publicado: (2015) -
Network meta-analysis of clinical trials of fluid treatments in sepsis demonstrates improved survival with albumin compared with crystalloid and hydroxyethyl starch
por: Bansal, M, et al.
Publicado: (2013) -
The Cost of Albumin Sepsis Treatment (COAST) study: efficacy analysis of albumin for severe sepsis. Modelling using the SAFE study and CUB-Rea data
por: Guidet, B, et al.
Publicado: (2006) -
Albumin infusion in spontaneous bacterial peritonitis: another brick off the wall?
por: Roux, Damien, et al.
Publicado: (2018) -
Effect of bacterial load versus duration of exposure to bacteria on plasma TNFα concentrations in porcine fecal peritonitis
por: Correa, T, et al.
Publicado: (2011)